Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy

Journal of Neuro-Oncology

Volumn 108, Issue 2, 2012, Pages 291-308

  Scoccianti, Silvia ^a   Detti, Beatrice ^a   Cipressi, Samantha ^a   Iannalfi, Alberto ^a   Franzese, Ciro ^a   Biti, Giampaolo ^a  

^a Azienda Ospedaliera   (Italy)

Author keywords

Brain metastases; Cognitive deficits; High grade and low grade gliomas; Neurotoxicity; Primary central nervous system lymphomas

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTINEOPLASTIC AGENT; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DONEPEZIL; DOXORUBICIN; ESTRAMUSTINE; HYDROCORTISONE; LOMUSTINE; MEMANTINE; MEPREDNISONE; METHOTREXATE; NITROSOUREA DERIVATIVE; PROCARBAZINE; RITUXIMAB; TEMOZOLOMIDE; TENIPOSIDE; THIOTEPA; VINCRISTINE;

ADULT; ALZHEIMER DISEASE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BRAIN DAMAGE; BRAIN INJURY; BRAIN METASTASIS; BRAIN RADIATION; BRAIN TUMOR; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVOR; COGNITIVE DEFECT; COMPUTER ASSISTED RADIOTHERAPY; DEMENTIA; DRUG MEGADOSE; GAIT DISORDER; GLIOBLASTOMA; GLIOMA; HUMAN; HYPERTENSION; INCONTINENCE; INTENSITY MODULATED RADIATION THERAPY; MALIGNANT TRANSFORMATION; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; OLIGODENDROGLIOMA; OVERALL SURVIVAL; PATIENT SELECTION; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RADIATION DOSE; RADIOSURGERY; REVIEW; THERAPY DELAY; TUMOR GROWTH; WHOLE BRAIN RADIOTHERAPY;

ADULT; BRAIN NEOPLASMS; COGNITION DISORDERS; HUMANS; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; RADIOTHERAPY;

EID: 84864036814     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0821-8     Document Type: Review

References (96)

1. Liu R, Page M, Solheim K, Fox S, Chang SM (2009) Quality of life in adults with brain tumors: current knowledge and future directions. Neuro Oncol 11:330-339
2. Meyers CA, Wefel JS (2003) The use of the mini-mental status examination to assess cognitive functioning in cancer trials: no ifs, ands, buts or sensitivity. J Clin Oncol 21:3557-3558 (Pubitemid 46594045)
3. Keime-Guibert F, Napolitano M, Delattre JY (1998) Neurological complications of radiotherapy and chemotherapy. J Neurol 245:695-708 (Pubitemid 28468468)
4. Laack NN, Brown PD, Ivnik RJ et al (2005) Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys 63:1175-1183 (Pubitemid 41505297)
5. Douw L, Klein M, Fagel SS et al (2002) Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol 8:810-818
6. Taphoorn MJ (2009) Neurocognitive effects of radiotherapy. American Society Clinical Oncology Annual Meeting, Educational book manuscript, pp 90-93
7. Klein M, Heimans JJ, Aaronson NK et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360:1361-1368 (Pubitemid 35341299)
8. Klein M, Engelberts NH, van der Ploeg HM et al (2003) Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54:514-520 (Pubitemid 37176548)
9. Reijneveld JC, Stitskoorn MM, Klein M et al (2001) Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas. Neurology 56:618-623 (Pubitemid 32209995)
10. Brown PD, Buckner JC, Uhm JH, Shaw EG (2003) The neurocognitive effects of radiation in adult low-grade glioma patients. Neuro Oncol 5:161-167 (Pubitemid 36790345)
11. Lesser GJ (2001) Chemotherapy of low -grade gliomas. Semin Radiat Oncol 11:138-144 (Pubitemid 32275221)
12. Olson JD, Riedel E, DeAngelis LM (2000) Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54:1442-1448 (Pubitemid 30210463)
13. Surma-aho O, Niemelä M, Vilkki J et al (2001) Adverse longterm effects of brain radiotherapy in adult low-grade glioma patients. Neurology 56:1285-1290 (Pubitemid 32455284)
14. Postma TJ, Klein M, Verstappen CC et al (2002) Radiotherapyinduced cerebral abnormalities in patients with low-grade glioma. Neurology 59:121-123 (Pubitemid 34742806)
15. Correa DD, Shi W, Thaler HT, Cheung AM, DeAngelis LM, Abrey LE (2008) Longitudinal cognitive follow-up in low grade gliomas. J Neurooncol 86:321-327
16. Vigliani MC, Sichez N, Poisson M, Delattre JY (1996) A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. Int J Radiat Oncol Biol Phys 35:527-533 (Pubitemid 26242901)
17. Armstrong CL, Hunter JV, Ledakis GE et al (2002) Late cognitive and radiographic changes related to radiotherapy: initial prospective findings. Neurology 59:40-48 (Pubitemid 34742792)
18. Brown PD, Buckner JC, O'Fallon JR et al (2003) Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol 21:2519-2524 (Pubitemid 46606333)
19. Torres IJ, Mundt AJ, Sweeney PJ et al (2003) A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors. Neurology 60:1113-1118 (Pubitemid 36418770)
20. Kiebert GM, Curran D, Aaronson NK et al (1998) Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomized phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer 34:1902-1908
21. Karim AB, Maat B, Hatlevoll R et al (1996) A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36:549-556 (Pubitemid 26404297)
22. Shaw E, Arusell R, Scheithauer B et al (2002) Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group Study. J Clin Oncol 20:2267-2276 (Pubitemid 34441653)
23. Thornton AF Jr, Hegarty TJ, Ten Haken RK et al (1991) Three dimensional treatment planning of astrocytomas: a dosimetric study of cerebral irradiation. Int J Radiat Oncol Biol Phys 20:1309-1315
24. Gregor A, Cull A, Traynor E, Stewart M, Lander F, Love S (1996) Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters. Radiother Oncol 41:55-59 (Pubitemid 26396297)
25. Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3:159-168 (Pubitemid 38229950)
26. Schiff D, Brown PD, Giannini C (2007) Outcome in adult lowgrade glioma: the impact of prognostic factors and treatment. Neurology 69:1366-1373 (Pubitemid 47482451)
27. van den Bent MJ, Afra D, de Witte O et al (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985-990 (Pubitemid 41323034)
28. Lote K, Egeland T, Hager B et al (1997) Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 15:3129-3140 (Pubitemid 27377505)
29. Pignatti F, van den Bent M, Curran D et al (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20:2076-2084 (Pubitemid 34408798)
30. Daniels TB, Brown PD, Felten SJ (2011) Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys 1:218-224
31. Shaw EG, Berkey B, Coons SW et al (2008) Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. J Neurosurg 109:835-841
32. Meyers CA, Smith JA, Bezjak A et al (2004) Neurocognitive function and progression in patients with brain metastases treated with whole brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22:157-165 (Pubitemid 41095128)
33. Regine WF, Scott C, Murray K, Curran W (2001) Neurocognitive outcome in brain metastases patients treated with accelerated fractionation vs. accelerated hyperfractionationated radiotherapy: an analysis from radiation therapy group study 91-04. Int J Radiat Oncol Biol Phys 51:711-717
34. Aoyama H, Tago M, Kato N et al (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68:1388-1395 (Pubitemid 47176822)
35. Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole brain irradiation: a randomized controlled trial. Lancet Oncol 10:1037-1044
36. Graham PH, Bucci J, Browne L (2010) Randomized comparison of whole brain radiotherapy, 20 Gy in four daily fractions versus 40 Gy in 20 twice-daily fractions, for brain metastases. Int J Radiat Oncol Biol Phys 77:648-654
37. Soffietti R, Mueller M, Abacioglu S et al (2010) Quality of life results of an EORTC phase III randomized trial of adjuvant whole brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases of solid tumors. J Clin Oncol 28:15s
38. Scott C, Suh J, Stea B, Nabid A, Hackman J (2007) Improved survival, quality of life and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole radiation therapy for brain metastases. Am J Clin Oncol 30:580-587 (Pubitemid 350307182)
39. Ahles TA, Saykin AJ, Furstenberg CT et al (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in longterm survivors of breast cancer and lymphoma. J Clin Oncol 20:485-493 (Pubitemid 34072533)
40. Soussain C, Ricard D, Fike JR et al (2009) CNS complications of radiotherapy and chemotherapy. Lancet 374:1639-1651
41. Vardy J, Wefel JS, Ahles T et al (2008) Cancer and cancertherapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 19:623-629 (Pubitemid 351461030)
42. Patchell RA, Tibbs PA, Regine WF et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain. A randomized trial. JAMA 280:1485-1489 (Pubitemid 28507400)
43. Kocher M, Soffietti R, Abacioglu U et al (2011) Adjuvant whole brain radiotherapy versus observation after radiosurgery or surgical resection of 1-3 cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29:134-141
44. Roos DE, Wirth A, Burmeister BH et al (2006) Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05). Radiother Oncol 80:318-322 (Pubitemid 44397210)
45. Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. A randomized controlled trial. JAMA 295:2483-2491 (Pubitemid 43854963)
46. Li J, Bentzen SM, Renschler M et al (2007) Regression after whole brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 25:1260-1266 (Pubitemid 46640573)
47. Khuntia D, Brown P, Li J, Mehta M (2006) Whole brain radiotherapy in the management of brain metastases. J Clin Oncol 24:1295-1304 (Pubitemid 46622033)
48. Borgelt B, Gelber R, Larson M, Hendrickson F, Griffin T, Roth R (1981) Ultra-rapid high dose irradiation for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 7:1633-1638 (Pubitemid 12212604)
49. Tofilon PJ, Fike JR (2000) The radioresponse of the central nervous system: a dynamic process. Radiat Res 153:357-370 (Pubitemid 30185388)
50. Monje ML, Palmer T (2003) Radiation injury and neurogenesis. Curr Opin Neurol 16:129-134 (Pubitemid 36521196)
51. Shors TJ, Miesagaes G, Beylin A, Whao M, Rydel T, Gould E (2001) Neurogenesis in the adult is involved in the formation of trace memories. Nature 410:372-376 (Pubitemid 32246054)
52. Byrne TN (2005) Cognitive sequelae of brain tumor treatment. Curr Opin Neurol 18:662-666 (Pubitemid 41669139)
53. Rola R, Raber J, Rizk A et al (2004) Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice. Exp Neurol 188:316-330 (Pubitemid 38891593)
54. Gondi V, TomèWA, Marsh J et al (2010) Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole brain radiotherapy: safety profile for RTOG 0933. Radiother Oncol 95:327-331
55. Weitzner MA, Meyers CA, Valentine AD (1995) Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment. J Neuropsychiatry Clin Neurosci 7:347-350
56. Chan AS, Cheung MC, Law SC et al (2004) Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis. Cancer 100:398-404 (Pubitemid 38063651)
57. Shaw EG, Rosdhal R, D'Agostino RB et al (2006) Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 24:1415-1420 (Pubitemid 46622007)
58. Robbins ME, Zhao W, Garcia-Espinosa MA, Diz DI (2010) Renin-angiotensin system blockers and modulation of radiationinduced brain injury. Curr Drug Targets 11:1413-1422
59. Sawrie SM, Guthrie BL, Spencer SA, Nordal RA, Meredith RF, Markert JM, Cloud GA, Fiveash JB (2008) Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. Int J Radiat Oncol Biol Phys 70:181-186 (Pubitemid 350251044)
60. Gaspar L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745-751 (Pubitemid 27181303)
61. Abrey LE, DeAngelis LM, Yahalom J (1998) Long-term survival in primary CNS lymphoma. J Clin Oncol 16:859-863 (Pubitemid 28108717)
62. Bessell EM, López-Guillermo A, VilláS et al (2002) Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments. J Clin Oncol 20:231-236 (Pubitemid 34032616)
63. Gavrilovic IT, Hormigo A, Yahalom J, DeAngelis LM, Abrey LE (2006) Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol 24:4570-4574 (Pubitemid 46630953)
64. Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment for primary CNS lymphoma: the next step. J Clin Oncol 18:3144-3150
65. Lai R, Abrey LE, Rosenblum MK, DeAngelis LM (2004) Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study. Neurology 62: 451-456 (Pubitemid 38200859)
66. O'Brien PC, Roos DE, Pratt G et al (2006) Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group). Int J Radiat Oncol Biol Phys 64:408-413 (Pubitemid 43083426)
67. Correa DD, Rocco-Donovan M, DeAngelis LM et al (2009) Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy. J Neurooncol 91:315-321
68. Abrey LE, Correa DD (2005) Treatment-related neurotoxicity. Hematol Oncol Clin N Am 19:729-738 (Pubitemid 41096716)
69. Fisher B, Seiferheld W, Schultz C et al (2005) Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma. J Neurooncol 74:201-205 (Pubitemid 41478919)
70. Ferreri AJ, Reni M, Pasini F et al (2002) A multicenter study of treatment of primary CNS lymphoma. Neurology 58:1513-1520 (Pubitemid 34552959)
71. DeAngelis LM, Seiferheld W, Schold SC et al (2002) Combination chemotherapy and radiotherapy for primary central nervous lymphoma. Radiation Therapy Oncology Group 93-100. J Clin Oncol 21:4643-4648 (Pubitemid 36025280)
72. Poortmans PM, Kluin-Nelemans HC, Haaxma-Reiche H et al (2003) High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. J Clin Oncol 21:4483-4488 (Pubitemid 46594017)
73. Harder H, Holtel H, Bromberg JE et al (2004) Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology 62:544-547 (Pubitemid 38252793)
74. Montemurro M, Kiefer T, Schüler F et al (2007) Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche Studiengruppe Hamato-Onkologie OSHO-53 phase II study. Ann Oncol 18:665-671 (Pubitemid 46523269)
75. Ferreri AJ, Reni M, Foppoli M et al (2009) High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet 374:1512-1520
76. Shibamoto Y, Hayabuchi N, Hiratsuka J et al (2003) Is wholebrain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation. Cancer 97:128-133 (Pubitemid 36033872)
77. Thiel E, Korfel A, Martus P et al (2010) High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol 11:1036-1047
78. Shaw EG, Wang M, Coons S et al (2006) 2008 Final report of Radiation Therapy Oncology Group (RTOG) protocol 9802: radiation therapy (RT) versus RT? procarbazine, CCNU, and vincristine (PCV) chemotherapy for adult low-grade glioma (LGG). J Clin Oncol 26:15S
79. Henriksson R, Asklund T, Poulsen HS (2011) Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review. J Neurooncol 104:639-646
80. Corn BW, Wang M, Fox S et al (2009) Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03. J Neurooncol 95:247-257
81. Archibald YM, Lunn D, Ruttan LA et al (1994) Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 80:247-253 (Pubitemid 24036495)
82. Hottinger AF, Yoon H, DeAngelis LM, Abrey LE (2009) Neurological outcome of long-term glioblastoma survivors. J Neurooncol 95:301-305
83. Veilleux N, Goffaux P, Boudrias M et al (2010) Quality of life in neurooncology-age matters. J Neurosurg 113:325-332
84. Klein M, Taphoorn MJ, Heimans JJ et al (2001) Neurobehavioral status and health-related quality of life in newly diagnosed high grade glioma patients. J Clin Oncol 19:4037-4047 (Pubitemid 32976690)
85. Talacchi A, Santini B, Savazzi S, Gerosa M (2011) Cognitive effects of tumour and surgical treatment in glioma patients. J Neurooncol 103:541-549
86. Taphoorn MJ, van den Bent MJ, Mauer ME et al (2007) Healthrelated quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial. J Clin Oncol 25:5723-5730
87. Yung WK, Albright RE, Olson J et al (2000) A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83:588-593 (Pubitemid 30636298)
88. Bosma I, Vos MJ, Heimans JJ et al (2007) The course of neurocognitive functioning in high-grade glioma patients. Neuro Oncol 9:53-62 (Pubitemid 46543489)
89. Keime-Guibert F, Chinot O, Taillandier L et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527-1535 (Pubitemid 46588417)
90. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996 (Pubitemid 40349501)
91. Taphoorn MJ, Stupp R, Coens C et al (2005) Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol 6:937-944 (Pubitemid 41685226)
92. Trojanowski T, Peszyński J, Turowski K et al (1989) Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy. J Neurosurg 70:18-23
93. Henriksson R, Malmström A, Bergström P et al (2006) Highgrade astrocytoma treated concomitantly with estramustine and radiotherapy. J Neurooncol 78:321-326 (Pubitemid 44018828)
94. Osoba D, Brada M, Yung WK, Prados M (2000) Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. J Clin Oncol 18:1481-1491 (Pubitemid 30205394)
95. Wang M, Cairncross G, Shaw E et al (2010) Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: Radiation Therapy Oncology Group trial 9402. Int J Radiat Oncol Biol Phys 77:662-669
96. Hassler MR, Elandt K, Preusser M et al (2010) Neurocognitive training in patients with high-grade glioma: a pilot study. J Neurooncol 97:109-115